Abstract. In the adult, dopamine inhibits prolactin (Prl) secretion and less so thyrotropin (TSH) (Roti et al. 1983 ). In the present study we have further
agonist, bromocriptine (5 mg), or placebo were randomly administered orally to 120 pregnant women during labour. Maternal and foetal cord blood was obtained at parturition and analyzed for Prl, TSH, T4, T3 and rT3 concentrations. Since the time of parturition is unpredictable, maternal and cord blood hormone values were grouped at intervals of time from the time of bromocriptine or placebo administration to delivery. Hormone values were compared between the bromocriptine and placebo groups by two-way analysis of variance (ANOVA). Bromocriptine markedly inhibited maternal serum Prl conentrations compared to values in the placebo treated women (P < 0.001) and this decrease was more marked as the time interval between bromocriptine administration and delivery increased (P < 0.001, regression analysis). Cord blood Prl was also significantly lower in newborns whose mothers received bromocriptine (P < 0.001 In adult mammals, thyrotropin (TSH) (Scanlon et al. 1979; Morley 1981) . In previous studies we have reported that TRH (Roti et al. 1981) and SRIH 0-30, 30-60, 60-90, 90-120, 120-180, 180-240, 240-300 and 300-425 (Fig. 1) (Fig. 2) . CB T4, T3 and rT3 concentrations were similar in the newborns whose mothers had received bromo¬ criptine or placebo (ANOVA) ( Table 3) .
Discussion
Tubero-infundibular DA is generally accepted as the major inhibitor of Prl secretion in man and animals (Scanlon et al. 1979 ). During pregnancy, markedly elevated serum Prl concentrations are usually present by the first trimester and continue elevated throughout pregnancy (Albrecht 1980 (Robuschi et al. 1983 ) and others (Arvela et al. 1983 ) that the maternal administration of the dopamine antagonist, metoclopramide, failed to increase foetal serum Prl concentration despite its effective placental transfer (Arvela et al. 1983 ). TRH, a known stimulator of Prl release, readily crosses the human placenta, yet its administration 
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11.1 (7) In the adult, an inhibitory effect of DA on TSH secretion has been suggested (Scanlon et al. 1979; Morley 1981) . Furthermore, an active role for dopaminergic tone on the regulation of the circa¬ dian rhythm of TSH secretion has been reported (Sowers et al. 1982 (Fisher et al. 1977; El-Zaheri et al. 1980; Roti et al. 1984) , are normally active in the term foetus.
